N

New Ray Medicine International Holding
6108

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$58.51M
EV
HK$6.74M
Shares Outstanding
190.26M
Beta
-4.61
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About New Ray Medicine International Holding Limited

gainify

N

New Ray Medicine International Holding Limited

6108

New Ray Medicine International Holding Limited, an investment holding company, engages in distribution and trading of injection drugs and pharmaceutical products in the People’s Republic of China. The company’s pharmaceutical products include injections, capsules, tab...

Sector

Industry

CEO

Wang, Qiuqin

Employees

30

IPO Date

Headquarters

Dikai International Center, B–C, 37th Floor, 19 Dangui Road, Hangzhou, Zhejiang Province China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.